Initial trial results show the new drug could slow dementia progression by 36 percent.
This article, images and content belong to the source and curated for informational purposes.
Get the latest creative news from FooBar about art, design and business.
Initial trial results show the new drug could slow dementia progression by 36 percent.
This article, images and content belong to the source and curated for informational purposes.